These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 10496407)

  • 21. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography.
    So SC; Hedges TR; Schuman JS; Quireza ML
    Ophthalmic Surg Lasers Imaging; 2003; 34(3):251-8. PubMed ID: 12757106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
    Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
    Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macular toxicity after short-term hydroxychloroquine therapy.
    Pasaoglu I; Onmez FE
    Indian J Ophthalmol; 2019 Feb; 67(2):289-292. PubMed ID: 30672499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing hydroxychloroquine toxicity by the multifocal ERG.
    Moschos MN; Moschos MM; Apostolopoulos M; Mallias JA; Bouros C; Theodossiadis GP
    Doc Ophthalmol; 2004 Jan; 108(1):47-53. PubMed ID: 15104166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of hydroxychloroquine retinopathy.
    Payne JF; Hubbard GB; Aaberg TM; Yan J
    Br J Ophthalmol; 2011 Feb; 95(2):245-50. PubMed ID: 20693556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.
    Missner S; Kellner U
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):319-25. PubMed ID: 22215255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.
    Tzekov R
    Doc Ophthalmol; 2005 Jan; 110(1):111-20. PubMed ID: 16249962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
    Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF
    Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy.
    Lai TY; Chan WM; Li H; Lai RY; Lam DS
    Am J Ophthalmol; 2005 Nov; 140(5):794-807. PubMed ID: 16310457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular toxicity of hydroxychloroquine.
    Tehrani R; Ostrowski RA; Hariman R; Jay WM
    Semin Ophthalmol; 2008; 23(3):201-9. PubMed ID: 18432546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxychloroquine retinopathy: A review of imaging.
    Pandya HK; Robinson M; Mandal N; Shah VA
    Indian J Ophthalmol; 2015 Jul; 63(7):570-4. PubMed ID: 26458473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy.
    Lai TY; Ngai JW; Chan WM; Lam DS
    Doc Ophthalmol; 2006 May; 112(3):177-87. PubMed ID: 16804707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinal toxicity secondary to Plaquenil therapy.
    Hanna B; Holdeman NR; Tang RA; Schiffman JS
    Optometry; 2008 Feb; 79(2):90-4. PubMed ID: 18215798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?
    Aduriz-Lorenzo PM; Aduriz-Llaneza P; Araiz-Iribarren J; Khamashta MA
    Lupus; 2020 Jun; 29(7):671-675. PubMed ID: 32316844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A subtle case of hydroxychloroquine retinopathy: spectral domain optical coherence tomography findings.
    Barnes AC; Bhavsar KV; Weber ML; Witkin AJ
    Eye (Lond); 2014 Dec; 28(12):1521-2. PubMed ID: 25214000
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinically evident chloroquine toxicity undetected by multifocal electroretinogram.
    Burnett HK; Somani R
    Can J Ophthalmol; 2012 Oct; 47(5):e31-3. PubMed ID: 23036562
    [No Abstract]   [Full Text] [Related]  

  • 38. RAPID ONSET HYDROXYCHLOROQUINE TOXICITY.
    Jeltsch BM; Sarraf D; Madjdpour D; Hanson JVM; Pfiffner FK; Koller S; Berger W; Barthelmes D; Al-Sheikh M
    Retin Cases Brief Rep; 2024 May; 18(3):351-354. PubMed ID: 36857194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.
    Greenstein VC; Amaro-Quireza L; Abraham ES; Ramachandran R; Tsang SH; Hood DC
    Doc Ophthalmol; 2015 Feb; 130(1):13-23. PubMed ID: 25502494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine.
    Tanga L; Centofanti M; Oddone F; Parravano M; Parisi V; Ziccardi L; Kroegler B; Perricone R; Manni G
    Graefes Arch Clin Exp Ophthalmol; 2011 May; 249(5):715-21. PubMed ID: 21253758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.